Key result
Extracorporeal ultrafiltration did not reduce the time to achieve a PCWP ≤18 mm Hg compared to conventional diuretic therapy in advanced heart failure.
Why the study?
Concerns exist regarding the safety and efficacy of ultrafiltration compared with conventional diuretic therapy in patients with advanced decompensated heart failure.
Does extracorporeal ultrafiltration reduce the time required to normalize pulmonary capillary wedge pressure compared to conventional diuretic therapy in patients with advanced decompensated heart failure?
RCT (n=36)
randomized
No
Does extracorporeal ultrafiltration reduce the time required to normalize pulmonary capillary wedge pressure compared to conventional diuretic therapy in patients with advanced decompensated heart failure?
In patients with advanced decompensated heart failure, ultrafiltration safely achieves greater volume removal and shorter hospital stay compared to conventional diuretics, despite not significantly reducing the time to normalize PCWP.
Answers are grounded in this paper and cite their sources.
Ultrafiltration does not hasten PCWP normalization; challenges its use for rapid decongestion targets in advanced HF and leaves secondary benefits for further trials.
Compared with conventional diuretic (CD) therapy, ultrafiltration (UF) is associated with greater weight loss and fewer re-hospitalizations in patients admitted with decompensated heart failure (HF). Concerns have been raised regarding its safety and efficacy in patients with more advanced heart failure. The authors conducted a single-center, prospective, randomized controlled trial in patients with advanced HF admitted to an intensive care unit for hemodynamically guided therapy, comparing UF (n=17) with CD (n=19) at admission. The primary end point was the time required for pulmonary capillary wedge pressure (PCWP) to be maintained at a value of ≤18 mm Hg for at least 4 consecutive hours. Secondary end points included levels of cytokines and neurohormones, as well as several clinical outcomes. In our study cohort, the time to achieve the primary end point was lower in the UF group but did not reach statistical significance (P = .08). UF resulted in greater weight reduction, higher total volume removed, and shorter hospital length of stay. There were no differences in kidney function, biomarkers, or adverse events. In patients with advanced HF under hemodynamically tailored therapy, UF can be safely performed to achieve higher average volume removed than CD therapy without leading to adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Hanna et al. (2011) conducted an RCT in Advanced Decompensated Heart Failure (n=36). Extracorporeal Ultrafiltration vs. Conventional diuretic therapy was evaluated on Time required for pulmonary capillary wedge pressure (PCWP) to be maintained at a value of ≤18 mm Hg for at least 4 consecutive hours (p=.08). Extracorporeal ultrafiltration did not reduce the time to achieve a PCWP ≤18 mm Hg compared to conventional diuretic therapy in advanced heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: